沃森肿瘤学治疗中国食管癌患者与厦门市肿瘤中心的一致性及适用性检验评价

Abstract
Figure/Table
References (18)
Related Citation (3)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the evaluation of the consistency and applicability test of Watson for Oncology in the treatment of patients with esophageal cancer in China and Xiamen Cancer Center. Methods From January 2016 to December 2019, a total of 200 patients with esophageal cancer treated by the expert team from Xiamen Cancer Center and finally adopted with multi disciplinary team (MDT) treatment plan were selected as the research objects. The patient's disease information was input into the WFO system, which provides personalized treatment advice for patients based on the disease information provided. The consistency and applicability of the treatment plan provided by WFO and the actual treatment plan of Xiamen Cancer Center were compared, and used Pearson correlation analysis to determine the correlation of the treatment protocol provided by WFO and the actual treatment protocol of Xiamen Cancer Center. Results The treatment regimen provided by WFO and the actual treatment protocol of Xiamen Cancer Center were compared, with consistency and applicability (P＞0.05). The results of the Pearson correlation analysis showed there was a correlation between the treatment regimen provided by WFO and the actual treatment protocol at Xiamen Cancer Center(P＜0.05). Conclusion There is a correlation between the treatment regimen provided by WFO and the actual treatment protocol at Xiamen Cancer Center. WFO has applicability in the formulation of treatment programs for Chinese esophageal cancer patients.

Key words： Watson for Oncology Esophageal cancer in China Xiamen cancer center Uniformity Applicability

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I30/95

[1]	徐君南，姜雨君，段羊羊，等.Watson for Oncology 在乳腺癌治疗中的应用与思考[J].中国研究型医院，2018，5（3）：19-24.
[2]	周娜，李爱芹，刘广伟，等.沃森肿瘤人工智能系统在临床中的应用[J].中国数字医学，2018，13（10）：28-30.
[3]	胡春雷，侯佳宁，靳枫，等.沃森肿瘤解决方案系统在我国结肠癌综合治疗决策中的应用价值评估[J].中国医学前沿杂志（电子版），2018，10（10）：116-120.
[4]	胡学达，杨焕明，赫捷，等.肿瘤基因组学与全球肿瘤基因组计划[J].科学通报，2015，60（9）:792-804.
[5]	段明月，叶玉琴，张乐，等.人工智能制定乳腺癌术后治疗方案与相关指南一致性研究[J].中国实用外科杂志，2019，12（9）：46-58.
[6]	Somashekhar SP，Sepúlveda，MJ，Puglielli S，et al.Watson for Oncology and breast cancer treatment recommendations：agreement with an expert multidisciplinary tumor board[J].Annals of Oncology，2018，12（9）：46-58.
[7]	Allison B，Heidi T，Alix H，et al.Preferences for models of peer support in the digital era：A cross-sectional survey of people with cancer[J].Psycho Oncology，2018，24（2）：98-104.
[8]	Xiaoyao Z，Yinbin Z，Xingcong M，et al.Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China[J].Jpn J Clin Oncot，2018，14（5）：132-145.
[9]	Frank X.Is Watson for Oncology per Se Unreasonably Dangerous：Making A Case for How to Prove Products Liability Based on a Flawed Artificial Intelligence Design[J].Medicine，2019，34（8）：565-573.
[10]	Fang J，Guo X，Zhu Z，et al.Quality control system of Watson for oncology：Artificial intelligence for supporting clinical decisions in oncology[J].J Clin Oncol，2019，37（15）：6616.
[11]	潘军，秦叔逵，陈映霞，等.转为可切除同时性肝转移结肠癌患者的肿瘤退缩分级与影像学评估的一致性观察[J].临床肿瘤学杂志，2018，48（7）：24-29.
[12]	马建华，尚玉萍，刘宝玲，等.累及野照射联合同步化疗治疗局部中晚期食管癌47 例临床观察[J].肿瘤学杂志，2018，24（12）：1223-1226.
[13]	顾翔，陈晓军，宋文波，等.再程放疗联合替吉奥治疗局部复发食管癌的临床疗效及安全性[J].国际肿瘤学杂志，2018，45（11）：661-664.
[14]	贺晓兰，徐晓婷.容积弧形调强治疗在食管癌中的应用[J].国际肿瘤学杂志，2018，45（8）：499-501.
[15]	刘娟，曹雪涛.2018年国内外免疫学研究重要进展[J].中国免疫学杂志，2019，35（1）：7-15.
[16]	胡其昌，张吉才，戴红政，等.美国临床遗传实验员认证规范介绍[J].中华医学遗传学杂志，2019，36（1）：44-53.
[17]	昝丽坤，谈东风.乳腺大体标本取材：美国MD 安德森癌症中心乳腺癌标本取材介绍[J].中华病理学杂志，2017，46（8）：521-524.
[18]	曹晖，顾佳毅.人工智能医疗给外科医生带来的挑战、机遇与思考[J].中国实用外科杂志，2018，38（1）：28-33.